Olema Stock Performance


USD 2.85  0.02  0.70%   

The company holds a Beta of 1.4252, which implies a somewhat significant risk relative to the market. Let's try to break down what Olema's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Olema Pharmaceuticals will likely underperform. Even though it is essential to pay attention to Olema Pharmaceuticals current trending patterns, it is always good to be careful when utilizing equity existing price patterns. Our philosophy towards forecasting any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Olema Pharmaceuticals exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Olema Pharmaceuticals has an expected return of -0.13%. Please be advised to check Olema Pharmaceuticals information ratio, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance to decide if Olema Pharmaceuticals performance from the past will be repeated at some point in the near future.
Olema Performance
0 of 100
Over the last 90 days Olema Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more

Olema Price Channel

Begin Period Cash Flow338549000.00
Total Cashflows From Investing Activities-275438000.00

Olema Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  347.00  in Olema Pharmaceuticals on September 2, 2022 and sell it today you would lose (60.00)  from holding Olema Pharmaceuticals or give up 17.29% of portfolio value over 90 days. Olema Pharmaceuticals is currently does not generate positive expected returns and assumes 6.0359% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than Olema, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Olema Pharmaceuticals is expected to under-perform the market. In addition to that, the company is 4.0 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.08 per unit of volatility.

Olema Pharmaceuticals Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Olema Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Olema Pharmaceuticals, and traders can use it to determine the average amount a Olema Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0217

Good Returns
Average Returns
Small Returns
Negative ReturnsOLMA
Estimated Market Risk
  actual daily
 52 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Olema Pharmaceuticals is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Olema Pharmaceuticals by adding it to a well-diversified portfolio.

About Olema Pharmaceuticals Performance

To evaluate Olema Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Olema Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Olema Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Olema Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Olema's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for womens cancers. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. Olema Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.

Things to note about Olema Pharmaceuticals

Checking the ongoing alerts about Olema Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Olema Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Olema Pharmaceuticals Alerts

Equity Alerts and Improvement Suggestions

Olema Pharmaceuticals generated a negative expected return over the last 90 days
Olema Pharmaceuticals has high historical volatility and very poor performance
Net Loss for the year was (71.1 M) with profit before overhead, payroll, taxes, and interest of 0.
Olema Pharmaceuticals currently holds about 240.71 M in cash with (50.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 85.0% of the company shares are owned by institutional investors
Please check Your Equity Center. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for analysis

When running Olema Pharmaceuticals price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Is Olema Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Olema Pharmaceuticals. If investors know Olema will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Olema Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
116.1 M
Return On Assets
Return On Equity
The market value of Olema Pharmaceuticals is measured differently than its book value, which is the value of Olema that is recorded on the company's balance sheet. Investors also form their own opinion of Olema Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Olema Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Olema Pharmaceuticals' market value can be influenced by many factors that don't directly affect Olema Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Olema Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Olema Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Olema Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.